The Health Sciences Authority in Singapore has advised manufacturers of high-risk medical devices, or Class C and D products, to comply with one of the three licensing requirements, including registration on the country's Medical Device Register or placement on the transition list. The HSA issued the notice as it reaches the third and final phase of the implementation of its regulatory framework for such devices.

Related Summaries